Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
84.63% of the Company’s AIM securities were not in public hands as of 13/11/23.
As quoted on their website: https://www.redxpharma.com/investor-centre/aim-rule-26/
Good luck everyone and as always DYOR.
Not that I'm aware of. Could be that someone has added the other circa 5.5% ,owned by other AXA entities, to the 5.5% owned by AXA Investment Managers UK.
https://www.morningstar.com/stocks/xlon/ibpo/ownership
Hi Trotsky - If a majority shareholder (owning 70%+ of the stock) could simply do as they choose, and deliberately prejudice minority shareholders (so as to devalue their shareholding, avoid paying equitable dividends etc), there quite simply wouldn't be any privately held companies with minority shareholders. In the UK I believe this is covered (but please don't quote me), as I'm no expert) under section 994 of the Companies Act 2006.
Additionally, I personally don't see what Aggarwal (with his 80%+ holding) motivation would be to treat other shareholders unfairly. Currently and understandably, given the recent demise of the share price, I can see why delisting the company isn't perceived to in the interests of the minority shareholders but who know's what might happen post delisting. Aggarwal's personal net worth has taken a hit of £200m+ in the last week, which I'm sure he has a plans to recover (and some) post delisting.
Anyway just my thoughts and appreciate the healthy debate.
Best and Good luck.
Trotsky - whilst I agree that a shareholder with over 75% can change the articles of association, the minority shareholder can pursue a legal claim if those amendments are unfairly prejudicial towards him/her. Personally I suspect a 'shareholders agreement' will be proposed post delist.
Best and GL.
Whether in a publicly held or privately owned company It’s illegal for a majority shareholder to intentionally prejudice the position of a minority shareholder. Additionally I fail to understand why Aggarwal would even attempt to do so when it’s likely he will own 90%+ of the business once this delists …assuming that it is EICR that are currently hoovering up the shares.
Good luck and as always DYOR.
The 'A Trades' marked as sells are most likely AXA and the other minority II's, which can't hold stock post delist, offloading. Once they're completely out, this could get interesting.
Good luck all.
Worth getting level 2 just to watch the volume of A trades going through. Surely must be EICR hoovering up more of the free float. Awaiting a TR1.
Good luck and as always DYOR.
you can buy now - real spread 1 vs 1.09 or thereabouts.
Good luck.
Looks like they're just flushing PI's out by raising/lowering the price by a couple of pence each way. I'd imagine funds are loading up given the amount of round trades. Quite possible we'll see a TR1 soon.
Accordingly, a total of 3,594,002 option awards are outstanding following these latest grants, which represents approximately 11.0 per cent. of the Company's existing issued share capital of 32,554,293 Ordinary Shares.
from the last RNS.
09:49:29 2.20 5,000,000 110.00k O
Fairly Sure Raj only had circa 780k shares. Don't think there's any overhang as took me 10 trades to buy just over £60k's worth this morning which suggests there's very little stock available.
Good luck & DYOR.
I might be wrong, but a more knowledgeable colleague of mine suggested that when duplicate trades are printed (one positive, the other negative) are shown they are often shorts closing/covering.
30-Sep-21 16:43:09 51.15 2,064,323 Sell* 51.52 51.64 1m O
30-Sep-21 16:43:09 51.1454 -2,064,323 Sell* 51.52 51.64 -1m O
GLA
The share's are very tightly held, so if you want to buy in quantity you have to pay a premium. To give you and example the 'ask' when I made my second purchase today was showing as £1.14p, but I had to pay just over £1.16 for £22k's worth. So our £200k buyer had to pay £1.30.
There should be some more liquidity tomorrow as the placing shares hit the market but I'd be surprised it anyone's tempted to sell at less than £1.30. Personally I think this will go much higher in the short term as Glyco news is imminent plus I'm hopeful that we might get an update soon re: the completion of the validation of the SARS-CoV-2 serology ELISA from ProAxis/AZ.
GLA & DYOR.
So we have institutions and directors happy to buy at £1.30p and £17m+ of our current market cap underwritten by our holding in PDSB plus cash. Fully diluted market cap is currently circa £25m, which roughly values all other investments at £8m only. Market cap should be at least £40m in my view and that's without news.
Good luck & DYOR.